Replies to post #1650 on GTC Biotherapeutics (fka GTCB)

[doofus_king]

It's probably because the management of GTCB snuck in another 100,000,000 shares into the LBF deal. On top of the ten year warrants that were issued to Harris Partners.

Let's face it. Cox and company are mostly concerned about keeping a job and the science.

Every shareholder can expect to be diluted by 100 percent or more in the next few years.

Is it worth it? Maybe.